Oxford/AstraZeneca jab effective against UK Covid variant, finds study
Oxford University scientists who developed the ChAdOx1-nCoV19 vaccine
have found that it remains effective against at least one of the new
variants of the disease, called the B.1.1.7 'Kent' coronavirus strain
after the south-east England region where it was first discovered late
last year.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/oxford/astrazeneca-jab-effective-against-uk-covid-variant-finds-study/articleshow/80734799.cms
have found that it remains effective against at least one of the new
variants of the disease, called the B.1.1.7 'Kent' coronavirus strain
after the south-east England region where it was first discovered late
last year.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/oxford/astrazeneca-jab-effective-against-uk-covid-variant-finds-study/articleshow/80734799.cms
Comments
Post a Comment